KR920009848A - 염기성 섬유아세포 성장인자 및 이의 생산방법 - Google Patents
염기성 섬유아세포 성장인자 및 이의 생산방법 Download PDFInfo
- Publication number
- KR920009848A KR920009848A KR1019910021053A KR910021053A KR920009848A KR 920009848 A KR920009848 A KR 920009848A KR 1019910021053 A KR1019910021053 A KR 1019910021053A KR 910021053 A KR910021053 A KR 910021053A KR 920009848 A KR920009848 A KR 920009848A
- Authority
- KR
- South Korea
- Prior art keywords
- growth factor
- fibroblast growth
- content
- basic fibroblast
- replaced
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factors [FGF]
- C07K14/503—Fibroblast growth factors [FGF] basic FGF [bFGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 Glu3, 5, Ser78, 96hbFGF cDNA의 구성이다.
제2도는 천연 hbFGF의 헤파린 HPLC이다. 제3도는 환원된 재조합 hbFGF의 헤파린 HPLC이다.
Claims (28)
- 하기 (a)-(c)로 구성되는 군으로부터 선택되는 염기성 섬유아세포 성장인자: (a) 3위치의 알라닌과 5위치의 세린이 글루탐산으로 대체된 약 155 아미노산을 갖는 염기성 섬유아세포 성장인자: (b) 3위치의 알라닌과 5위치의 세린이 글루탐산으로 대체되고, 78과 96위치의 시스테인은 이설파이드 스크램블링을 제거하는 아미노산으로 대체된 약 155 아미노산을 갖는 염기성 섬유아세포 성장인자; 및 (c) N-말단 메티오닌이 없는 (a)와 (b)의 절단 형태.
- 제1항에 있어서, 상기 염기성 섬유아세포 성장인자는 재조합체인 염기성 섬유아세포 성장인자.
- 제2항에 있어서, 78과 96위치의 시스테인은 세린, 리신, 아스파르트산, 글루탐산, 아스파라긴, 글루타민, 히스티딘, 이소토이신, 로이신, 발린, 페닐알라닌, 티로신, 메티오닌, 쓰레오닌, 프롤린, 알라닌, 글리신, 아르기닌 또는 트립토판으로 대체되는 재조합체인 염기성 섬유아세포 성장인자.
- 제3항에 있어서, 78과 96위치의 시스테인은 세린으로 대체되는 재조합체인 염기성 섬유아세포 성장인자.
- 제2항에 있어서, glu3, 5hbFGF를 포함하는 재조합체인 염기성 섬유아세포 성장인자.
- 제4항에 있어서, glu3, 5ser78, 97hbFGF를 포함하는 재조합체인 염기성 섬유아세포 성장인자.
- 제2항에 따른 성장인자를 암호하는 DNA 서열을 포함하는 생물학적 기능이 있는 원형 플라스미드 또는 비루스 DNA 베터.
- 제7항에 있어서, pET-3a 유도체를 포함하는 벡터.
- 제8항에 있어서, RNA 폴리머라제로부터의 T7프로모터를 함유하는 pT7 Kan와 pET-3a(M13)로 구성되는 군으로부터 선택되는 벡터.
- 숙주세포가 상기 인자를 발현하도록 하는 방식으로 제7항의 벡터로 형질전환되거나 트랜스펙트된 원핵생물 또는 진핵생물 숙주세포.또는 하나 또는 두개의 카르복실산 또는 황산기로 임의로 치환된 페닐이고; n은 0 내지 4의 정수이고; m은 2 내지 4의 정수이고; x는 1 내지 3의 정수임)로부터 선택된 치환체로 유도체화된 염기성 섬유아세포 성장인자.
- 내용없음
- 내용없음
- 내용없음
- 내용없음
- 내용없음
- 내용없음
- 내용없음
- 내용없음
- 내용없음
- 내용없음
- 내용없음
- 내용없음
- 내용없음
- 내용없음
- 내용없음
- 내용없음
- 제26항에 있어서, 상기 염기성 섬유아세포 성장인자를 카르복시메틸화된 섬유아세포 성장인자의 염기성 섬유아세포 성장인자.
- 제27항에 있어서, 상기 섬유아세포 성장인자는 glu3, 5hbFGF인 염기성 섬유아세포 성장인자.※참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61520290A | 1990-11-23 | 1990-11-23 | |
US7/615,202 | 1990-11-23 | ||
US07/615,202 | 1990-11-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR920009848A true KR920009848A (ko) | 1992-06-25 |
KR100205078B1 KR100205078B1 (ko) | 1999-06-15 |
Family
ID=24464425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019910021053A KR100205078B1 (ko) | 1990-11-23 | 1991-11-22 | 염기성 섬유 아세포 성장인자 및 이의 생산방법 |
Country Status (16)
Country | Link |
---|---|
US (3) | US5310883A (ko) |
EP (1) | EP0486862B1 (ko) |
JP (1) | JP3205578B2 (ko) |
KR (1) | KR100205078B1 (ko) |
AT (1) | ATE138687T1 (ko) |
AU (1) | AU646514B2 (ko) |
CA (1) | CA2055963C (ko) |
DE (1) | DE69119869T2 (ko) |
DK (1) | DK0486862T3 (ko) |
ES (1) | ES2087207T3 (ko) |
GR (1) | GR3020237T3 (ko) |
IE (1) | IE74956B1 (ko) |
IL (1) | IL99984A (ko) |
NZ (1) | NZ240622A (ko) |
PT (1) | PT99565B (ko) |
ZA (1) | ZA919260B (ko) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7252929B2 (en) | 1989-02-09 | 2007-08-07 | United States Of America, As Represented By The Secretary, Dept Of Health & Human Services | Methods for identifying alpha PDGFR agonists and antagonists |
US5951972A (en) * | 1990-05-04 | 1999-09-14 | American Cyanamid Company | Stabilization of somatotropins and other proteins by modification of cysteine residues |
US5206354A (en) * | 1990-11-23 | 1993-04-27 | American Cyanamid Company | Dna sequence encoding active fragment of fibroblast growth factor, hbf-2 |
EP0486862B1 (en) * | 1990-11-23 | 1996-05-29 | American Cyanamid Company | Chimeric fibroblast growth factor |
KR100374310B1 (ko) * | 1995-02-14 | 2003-05-22 | 주식회사 엘지생명과학 | 변형된인간염기성섬유아세포성장인자및이의생산방법 |
EP0880598A4 (en) * | 1996-01-23 | 2005-02-23 | Affymetrix Inc | RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM |
ES2247621T3 (es) | 1996-02-15 | 2006-03-01 | Biosense Webster, Inc. | Sonda de excavacion. |
US6927287B1 (en) * | 1996-06-03 | 2005-08-09 | United States Surgical Corporation | Nucleic acid encoding extracellular matrix protein or fragment thereof |
US6492508B1 (en) * | 1996-06-03 | 2002-12-10 | United States Surgical Corp. A Division Of Tyco Healthcare Group | Nucleic acids encoding extracellular matrix proteins |
US6443974B1 (en) * | 1996-07-28 | 2002-09-03 | Biosense, Inc. | Electromagnetic cardiac biostimulation |
US20030144202A1 (en) * | 1996-10-15 | 2003-07-31 | Amgen Inc. | Uses of keratinocyte growth factor-2 |
US6743422B1 (en) | 1996-10-15 | 2004-06-01 | Amgen, Inc. | Keratinocyte growth factor-2 products |
US6274712B1 (en) | 1997-12-23 | 2001-08-14 | 3-Dimensional Pharmaceuticals, Inc. | Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137 |
US20030113303A1 (en) * | 1998-02-05 | 2003-06-19 | Yitzhack Schwartz | Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances |
US20030129750A1 (en) * | 1998-02-05 | 2003-07-10 | Yitzhack Schwartz | Homing of donor cells to a target zone in tissue using active therapeutics or substances |
ES2255155T3 (es) | 1998-02-05 | 2006-06-16 | Biosense Webster, Inc. | Dispositivo para la administracion intracardiaca de farmacos. |
AU760664B2 (en) * | 1998-04-17 | 2003-05-22 | Angiogenix, Inc. | Therapeutic angiogenic factors and methods for their use |
US5929051A (en) * | 1998-05-13 | 1999-07-27 | Carrington Laboratories, Inc. | Aloe pectins |
US7022683B1 (en) * | 1998-05-13 | 2006-04-04 | Carrington Laboratories, Inc. | Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation |
US6313103B1 (en) | 1998-05-13 | 2001-11-06 | Carrington Laboratories, Inc. | Pectic substance as a growth factor stabilizer |
US8618052B2 (en) | 1998-10-13 | 2013-12-31 | Novartis Vaccines And Diagnostics, Inc. | Method of treating coronary artery disease by administering FGF-5 |
EP1121141A2 (en) * | 1998-10-13 | 2001-08-08 | Chiron Corporation | Angiogenically effective unit dose of fgf and method of administering |
US20030166550A1 (en) | 1999-08-27 | 2003-09-04 | Chiron Corporation | Angiogenically effective unit dose of FGF-2 and method of use |
US20020072489A1 (en) * | 1998-10-13 | 2002-06-13 | Whitehouse Martha J. | Angiogenically effective unit dose of FGF-2 and method of use |
US6440934B1 (en) | 1998-10-13 | 2002-08-27 | Chiron Corporation | Angiogenically effective unit dose of FGF-2 and method of use |
AU6634400A (en) * | 1999-08-13 | 2001-03-13 | Chiron Corporation | Dose of an angiogenic factor and method of administering to improve myocardial blood flow |
US7494669B2 (en) | 2001-02-28 | 2009-02-24 | Carrington Laboratories, Inc. | Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
IL149562A0 (en) * | 2002-05-09 | 2002-11-10 | Prochon Ltd | Fgf variants and methods for use thereof |
US7067123B2 (en) | 2003-04-29 | 2006-06-27 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
US7901457B2 (en) | 2003-05-16 | 2011-03-08 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
US20090319045A1 (en) | 2004-10-12 | 2009-12-24 | Truncale Katherine G | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
US7815926B2 (en) | 2005-07-11 | 2010-10-19 | Musculoskeletal Transplant Foundation | Implant for articular cartilage repair |
JP2009508596A (ja) | 2005-09-19 | 2009-03-05 | ヒストジェニックス コーポレイション | 細胞支持基材及びその調製方法 |
US8435551B2 (en) | 2007-03-06 | 2013-05-07 | Musculoskeletal Transplant Foundation | Cancellous construct with support ring for repair of osteochondral defects |
US20090054984A1 (en) | 2007-08-20 | 2009-02-26 | Histogenics Corporation | Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects |
US8685107B2 (en) | 2007-07-03 | 2014-04-01 | Histogenics Corporation | Double-structured tissue implant and a method for preparation and use thereof |
CN102076352B (zh) * | 2008-05-02 | 2016-06-15 | 西安大略大学 | 与血管有关的fgf-9和它的用途 |
US9169309B2 (en) * | 2011-03-01 | 2015-10-27 | Humanzyme Inc. | Thermostable variants of fibroblast growth factors |
US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
CN105859892A (zh) * | 2016-06-08 | 2016-08-17 | 浙江大学 | 一种类胶原蛋白-人碱性成纤维细胞生长因子融合蛋白及其制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4378347A (en) * | 1980-06-30 | 1983-03-29 | Franco Wayne P | Composition for treating the heart for myocardial infarction |
US4296100A (en) * | 1980-06-30 | 1981-10-20 | Franco Wayne P | Method of treating the heart for myocardial infarction |
US4588585A (en) * | 1982-10-19 | 1986-05-13 | Cetus Corporation | Human recombinant cysteine depleted interferon-β muteins |
US4518584A (en) * | 1983-04-15 | 1985-05-21 | Cetus Corporation | Human recombinant interleukin-2 muteins |
US4785079A (en) * | 1984-11-09 | 1988-11-15 | The Salk Institute For Biological Studies | Isolation of fibroblast growth factor |
US4956455A (en) * | 1984-03-05 | 1990-09-11 | The Salk Institute For Biological Studies | Bovine fibroblast growth factor |
US4959314A (en) * | 1984-11-09 | 1990-09-25 | Cetus Corporation | Cysteine-depleted muteins of biologically active proteins |
WO1989000198A1 (en) * | 1987-07-07 | 1989-01-12 | Biotechnology Research Associates, J.V. | Recombinant fibroblast growth factors |
US4902782A (en) * | 1986-12-10 | 1990-02-20 | The Salk Institute For Biological Studies | Isolation of fibroblast growth factor |
KR890701607A (ko) * | 1987-11-24 | 1989-12-21 | 원본미기재 | 섬유아세포 성장 인자의 유사체 |
US5130418A (en) * | 1989-05-02 | 1992-07-14 | California Biotechnology Inc. | Method to stabilize basic fibroblast growth factor |
EP0486862B1 (en) * | 1990-11-23 | 1996-05-29 | American Cyanamid Company | Chimeric fibroblast growth factor |
DE19681529D2 (de) * | 1996-06-29 | 1999-10-14 | Dieter Mueller | Pharmazeutische Darreichungsform |
-
1991
- 1991-11-04 EP EP91118725A patent/EP0486862B1/en not_active Expired - Lifetime
- 1991-11-04 US US07/783,694 patent/US5310883A/en not_active Expired - Lifetime
- 1991-11-04 ES ES91118725T patent/ES2087207T3/es not_active Expired - Lifetime
- 1991-11-04 DE DE69119869T patent/DE69119869T2/de not_active Expired - Fee Related
- 1991-11-04 AT AT91118725T patent/ATE138687T1/de not_active IP Right Cessation
- 1991-11-04 DK DK91118725.0T patent/DK0486862T3/da active
- 1991-11-07 IL IL9998491A patent/IL99984A/en active IP Right Grant
- 1991-11-18 NZ NZ240622A patent/NZ240622A/en not_active IP Right Cessation
- 1991-11-21 PT PT99565A patent/PT99565B/pt not_active IP Right Cessation
- 1991-11-21 CA CA002055963A patent/CA2055963C/en not_active Expired - Fee Related
- 1991-11-21 JP JP33156891A patent/JP3205578B2/ja not_active Expired - Fee Related
- 1991-11-22 KR KR1019910021053A patent/KR100205078B1/ko not_active IP Right Cessation
- 1991-11-22 IE IE406891A patent/IE74956B1/en not_active IP Right Cessation
- 1991-11-22 AU AU88062/91A patent/AU646514B2/en not_active Ceased
- 1991-11-22 ZA ZA919260A patent/ZA919260B/xx unknown
-
1993
- 1993-02-26 US US08/023,757 patent/US5302702A/en not_active Expired - Lifetime
-
1994
- 1994-01-05 US US08/177,502 patent/US5371206A/en not_active Expired - Lifetime
-
1996
- 1996-06-17 GR GR950403456T patent/GR3020237T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
IE74956B1 (en) | 1997-08-13 |
KR100205078B1 (ko) | 1999-06-15 |
PT99565B (pt) | 1999-04-30 |
IL99984A0 (en) | 1992-08-18 |
JP3205578B2 (ja) | 2001-09-04 |
EP0486862B1 (en) | 1996-05-29 |
ATE138687T1 (de) | 1996-06-15 |
GR3020237T3 (en) | 1996-09-30 |
ES2087207T3 (es) | 1996-07-16 |
DE69119869D1 (de) | 1996-07-04 |
DE69119869T2 (de) | 1996-12-12 |
JPH04330097A (ja) | 1992-11-18 |
CA2055963C (en) | 2002-11-12 |
US5371206A (en) | 1994-12-06 |
US5302702A (en) | 1994-04-12 |
PT99565A (pt) | 1992-10-30 |
US5310883A (en) | 1994-05-10 |
CA2055963A1 (en) | 1992-05-24 |
ZA919260B (en) | 1992-08-26 |
IE914068A1 (en) | 1992-06-03 |
DK0486862T3 (da) | 1996-06-24 |
EP0486862A1 (en) | 1992-05-27 |
AU646514B2 (en) | 1994-02-24 |
NZ240622A (en) | 1994-08-26 |
IL99984A (en) | 1998-12-06 |
AU8806291A (en) | 1992-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR920009848A (ko) | 염기성 섬유아세포 성장인자 및 이의 생산방법 | |
SI20643B (sl) | IL-2-selektivni agonisti in antagonisti | |
DeLange et al. | Calf and Pea Histone IV: I. Amino acid compositions and the identical cooh-terminal 19-residue sequence | |
KR960700340A (ko) | 안정한 살균/투과성-증가 단백질 생성물 및 그를 포함하는 제약학적 조성물(stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same) | |
ES2070322T3 (es) | Polipeptidos biologicamente activos basados en las secuencias del factor de crecimiento de transformacion beta. | |
PT670898E (pt) | Polipeptidos de multiplas mutacoes de interleucina-3 (il-3) | |
DK0458959T3 (da) | Hidtil ukendte blodpladeafledte vækstfaktor B-kædeanaloger og fremgangsmåde til homogen fremstilling deraf | |
AU579142B2 (en) | Purification, cloning and characterization of the gene for interleukin 1 | |
DE170917T1 (de) | Neues derivat des humangammainterferon-polypeptids. | |
Traub et al. | Contribution of the α2 chain to the molecular stability of collagen | |
Canova-Davis et al. | Characterization of chemically synthesized human relaxin by high-performance liquid chromatography | |
KR920009413A (ko) | 소마토트로핀 | |
TILLET‐BARRET et al. | Characterization of heterotrimeric collagen molecules in a sea‐pen (Cnidaria, Octocorallia) | |
EP0361956A3 (en) | Increased expression of small molecular weight recombinant proteins | |
Lauren et al. | Covalent dimerization of recombinant human interferon-γ | |
JPWO2021107603A5 (ko) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20050114 Year of fee payment: 7 |
|
LAPS | Lapse due to unpaid annual fee |